Cargando…
Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia
BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960168/ https://www.ncbi.nlm.nih.gov/pubmed/24647042 http://dx.doi.org/10.1371/journal.pone.0092021 |
_version_ | 1782308129657061376 |
---|---|
author | Rathakrishnan, Anusyah Klekamp, Benjamin Wang, Seok Mui Komarasamy, Thamil Vaani Natkunam, Santha Kumari Sathar, Jameela Azizan, Azliyati Sanchez-Anguiano, Aurora Manikam, Rishya Sekaran, Shamala Devi |
author_facet | Rathakrishnan, Anusyah Klekamp, Benjamin Wang, Seok Mui Komarasamy, Thamil Vaani Natkunam, Santha Kumari Sathar, Jameela Azizan, Azliyati Sanchez-Anguiano, Aurora Manikam, Rishya Sekaran, Shamala Devi |
author_sort | Rathakrishnan, Anusyah |
collection | PubMed |
description | BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY AND FINDINGS: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. CONCLUSION: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings. |
format | Online Article Text |
id | pubmed-3960168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39601682014-03-24 Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia Rathakrishnan, Anusyah Klekamp, Benjamin Wang, Seok Mui Komarasamy, Thamil Vaani Natkunam, Santha Kumari Sathar, Jameela Azizan, Azliyati Sanchez-Anguiano, Aurora Manikam, Rishya Sekaran, Shamala Devi PLoS One Research Article BACKGROUND: With its elusive pathogenesis, dengue imposes serious healthcare, economic and social burden on endemic countries. This study describes the clinical and immunological parameters of a dengue cohort in a Malaysian city, the first according to the WHO 2009 dengue classification. METHODOLOGY AND FINDINGS: This longitudinal descriptive study was conducted in two Malaysian hospitals where patients aged 14 and above with clinical symptoms suggestive of dengue were recruited with informed consent. Among the 504 participants, 9.3% were classified as non-dengue, 12.7% without warning signs, 77.0% with warning signs and 1.0% with severe dengue based on clinical diagnosis. Of these, 37% were misdiagnosed as non-dengue, highlighting the importance of both clinical diagnosis and laboratory findings. Thrombocytopenia, prolonged clotting time, liver enzymes, ALT and AST served as good markers for dengue progression but could not distinguish between patients with and without warning signs. HLA-A*24 and -B*57 were positively associated with Chinese and Indians patients with warning signs, respectively, whereas A*03 may be protective in the Malays. HLA-A*33 was also positively associated in patients with warning signs when compared to those without. Dengue NS1, NS2A, NS4A and NS4B were found to be important T cell epitopes; however with no apparent difference between with and without warning signs patients. Distinction between the 2 groups of patients was also not observed in any of the cytokines analyzed; nevertheless, 12 were significantly differentially expressed at the different phases of illness. CONCLUSION: The new dengue classification system has allowed more specific detection of dengue patients, however, none of the clinical parameters allowed distinction of patients with and without warning signs. While the HLA-A*33 may be predictive marker for development of warning signs; larger studies will be needed to support this findings. Public Library of Science 2014-03-19 /pmc/articles/PMC3960168/ /pubmed/24647042 http://dx.doi.org/10.1371/journal.pone.0092021 Text en © 2014 Rathakrishnan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Rathakrishnan, Anusyah Klekamp, Benjamin Wang, Seok Mui Komarasamy, Thamil Vaani Natkunam, Santha Kumari Sathar, Jameela Azizan, Azliyati Sanchez-Anguiano, Aurora Manikam, Rishya Sekaran, Shamala Devi Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title | Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title_full | Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title_fullStr | Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title_full_unstemmed | Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title_short | Clinical and Immunological Markers of Dengue Progression in a Study Cohort from a Hyperendemic Area in Malaysia |
title_sort | clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in malaysia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960168/ https://www.ncbi.nlm.nih.gov/pubmed/24647042 http://dx.doi.org/10.1371/journal.pone.0092021 |
work_keys_str_mv | AT rathakrishnananusyah clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT klekampbenjamin clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT wangseokmui clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT komarasamythamilvaani clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT natkunamsanthakumari clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT satharjameela clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT azizanazliyati clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT sanchezanguianoaurora clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT manikamrishya clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia AT sekaranshamaladevi clinicalandimmunologicalmarkersofdengueprogressioninastudycohortfromahyperendemicareainmalaysia |